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Guanine nucleotide exchange factorElmo is an evolutionarily conserved mammalian ortholog of Caenorhabditis elegans CED-12 with proposed roles
during the removal of apoptotic cells, cell migration, neurite outgrowth, andmyoblast fusion (Katoh and Negishi
(2003) [1], Park and Tosello (2007) [2], Grimsley et al. (2004) [3], Hamoud et al. (2014) [4]). Elmomediates these
cellular processes by interacting with various proteins located in the plasmamembrane, cytoplasm and nucleus,
and by modulating their activities although it has no intrinsic catalytic activity (Park and Tosello (2007) [2],
Hamoud et al. (2014) [4], Li et al. (2013) [5], Margaron, Fradet and Cote (2013) [6], and Mauldin et al. (2013)
[7]). Because there are a limited number of proteins known to interact with Elmo, we performed a yeast two-
hybrid screen using Elmo1 as bait to identify Elmo1-interacting proteins and to evaluate theirmode of regulation.
Arhgef16 was one of the proteins identiﬁed through the screen and subsequent analyses revealed that Arhgef16
interacted with Elmo1 in mammalian cells as well. Expression of Arhgef16 in phagocytes promoted engulfment
of apoptotic cells, and engulfment mediated by Arhgef16 increased synergistically in the presence of Elmo1 but
was abrogated in the absence of Elmo1. In addition, Arhgef16-mediated removal of apoptotic cells was depen-
dent on RhoG, but independent of Dock1. Taken together, this study suggests that the newly identiﬁed Elmo1-
interacting protein, Arhgef16, functions synergistically with Elmo1 to promote clearance of apoptotic cells in a
RhoG-dependent and Dock1-independent manner.F, guanine nucleotide exchange
nsferase; AG16, Arhgef16; E1,
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; RT-PCR, reverse transcriptase-
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Clearance of apoptotic cells in multicellular organisms is important
for preventing secondary necrosis and inﬂammation and removal of
apoptotic cells is critical for maintaining tissue homeostasis and for
regulating immune responses [8–10]. Elmo, one of the key proteins
involved in this process, is a mammalian homolog of CED-12 in
Caenorhabditis elegans and is evolutionarily conserved from worms to
mammals. Elmo is known to be involved in various cellular processessuch as phagocytosis, cell migration, neurite outgrowth, and formation
of cellular protrusions via cytoskeleton remodeling [1,2,5,6,11,12]. In-
terestingly, Elmo regulates these processes by modulating the activities
of other proteins and by serving as a scaffold for transferring signals to
other downstream molecules through protein–protein interactions de-
spite lacking any intrinsic catalytic activity [1,12–15].
One well-known Elmo-interacting protein whose activity is regulat-
ed by Elmo is Dock1. Dock1 is anunconventional guanine nucleotide ex-
change factor (GEF) for Rac because it has a docker domain in place of
the Dbl homology domain found in conventional GEFs [13,16]. It has
been proposed that Elmo can regulate the GEF activity of Dock1 by
several different mechanisms: the N-terminus of Elmo targets the
Elmo–Dock1 complex to the plasma membrane where the complex
has easy access to Rac1; Elmo also relieves the self-inhibitory state of
Dock1 caused by the binding of the SH3 domain to the docker domain
via the interaction between the PXXP motif of Elmo1 and the SH3 do-
main of Dock1; ﬁnally Elmo helps Dock1 to stabilize nucleotide-free
Rac1 in the transition state. Thus, Elmo helps tomodulate the GEF activ-
ity of Dock1 by a variety of mechanisms [12,14,15].
In addition to Dock1, a few other proteins that interact with Elmo
have been identiﬁed. RhoG is a member of the Rho family of small
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neurite outgrowth in neuronal cells, which requires the activation of
Rac1. The GTP bound form of RhoG, but not the inactive form, speciﬁcal-
ly binds to the N-terminus of Elmo. The C-terminus of Elmo binds to
Dock1 simultaneously to form a ternary complex capable of activating
Rac1. Thus, Elmo is a mediator that links RhoG activation to Rac1 by
interacting with both RhoG and Dock1 [1,17,18].
Another interesting Elmo-interacting protein, BAI1, is a member of
the class of adhesion G-protein coupled receptors (GPCRs) which func-
tions as an engulfment receptor for apoptotic cells upstream of the
Elmo–Dock1–Rac module. Once apoptotic cells are recognized by the
TSR domain in the extracellular region of BAI, the apoptotic cell recogni-
tion signals are transferred to the Elmo–Dock1 complex to activate Rac1
upon engagement of Elmo by the cytoplasmic tail of BAI1. Activated
Rac1 subsequently directs the engulfment of apoptotic cells by cytoskel-
etal rearrangement [2]. Also, BAI1 recognizes apoptotic myoblasts and
facilitates the formation of myoﬁbers by signaling through the Elmo–
Dock1–Rac1 module [19]. Recently, Bai3, a mouse homolog of BAI1,
was found to interact with Elmo and to promote myoblast fusion [4].
Thus, Elmo is involved inmany cellular processes bymodulating the ac-
tivities of interacting proteins or by functioning as a scaffold.
Arhgef16 (Ephexin4) is a member of the Ephexin subfamily of Rho
guanine nucleotide exchange factors. Five members of the Ephexin
family have been identiﬁed so far but the details of their roles in various
cellular processes are still being determined. However, Ephexin1 has
been relatively well characterized in neuronal cells where it functions
as a GEF for RhoA and is important for regulating axon guidance and
spine morphogenesis via its interaction with EphA4 [20–22]. However,
the roles of Ephexin-1, -2, -3 and -5 are less well understood although
they are known to activate RhoA [20,21,23–25].
It was shown recently that Arhgef16 interacts with nucleotide-free
RhoG or Rac1 but acts only as a RhoG-speciﬁc GEF, although it ultimate-
ly activates Rac1 via the RhoG–Elmo–Dock4 pathway. Also, Arhgef16
binds to the ephrin receptor A2 (EphA2) and promotes migration and
invasion of breast cancer cells through a RhoG-dependent mechanism
[26]. In addition, Arhgef16 renders cancer cells resistant to apoptosis
by activating RhoG and PI3K downstream of EphA2 [26,27]. In contrast,
the cellular function and biochemical properties of Ephexin4 are un-
known in phagocytes during clearance of apoptotic cells.
We have identiﬁed Arhgef16 as an Elmo1-interacting protein from a
yeast two-hybrid screen. Arhgef16 interacted with Elmo1 in yeast and
mammalian cells and the possibility of a direct protein–protein interac-
tion was demonstrated in vitro. Arhgef16 was capable of enhancing en-
gulfment of apoptotic cells, and this enhanced removal of apoptotic cells
was augmented by co-expression of Elmo1. The increased removal of
apoptotic cells was the result of a synergy between Arhgef16 and
Elmo1 in a RhoG-dependent and Dock1-independent manner. Here,
we report a novel Elmo1-interacting protein, Arhgef16, capable of pro-
moting removal of apoptotic cells.2. Materials and methods
2.1. Cell cultures and transfections
293 T cells, J774 cells,MEF (mouse embryonic ﬁbroblast), L cells, and
primary astrocytes were maintained in DMEM supplemented with 10%
FBS and 1% penicillin–streptomycin–glutamine, whereas LR73 cells
were cultured in alpha-MEM with 10% FBS and 1% penicillin–strepto-
mycin–glutamine. 293 T cells were transfected using the Profection
mammalian transfection system (Promega) and the LR73 cells and
L cells were transfected with Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer's instructions. Nucleofection (Lonza) was
used to introduce plasmids and siRNA (Dharmacon, smart pool) into
J774 cells (kit V, program T-20), primary astrocytes (astrocyte kit, pro-
gram T-20), and MEF (MEF2, program T-20).2.2. Plasmids and antibodies
All plasmids generated in this studywere sequenced to conﬁrm their
identity. The yeast clone N20was used as a template to amplify smaller
fragments of Arhgef16 and to generate FLAG-N20 and pEBG-N20. The
mouse Arhgef16 cDNA, Ephexin-1 and Ephexin-2 cDNAs were pur-
chased from Open Biosystems to construct pEBB-Arhgef16, pEBB-
Arhgef16-FLAG, pEBB-Arhgef16-GFP, pEBB-Ephexin-1-FLAG, pEBB-
Ephexin-2-FLAG and pGEX-4T-2-Arhgef16 by a PCR-based strategy in
pEBB-FLAG, pEBB-GFP or pGEX-4T-2 vector. The Elmo1, Dock1, RhoG
and Rac1 constructs used in this study have been described previously
[2]. The antibodies used in the study were anti-FLAG (Sigma, M2),
anti-GFP (Santa Cruz, B-2) and anti-GST (Santa Cruz, Z-5). The anti-
Arhgef16 antibody and the anti-Elmo1 antibody were purchased from
Proteintech and Bethyl Laboratories (A301-961A) and Santa Cruz Bio-
technology (C-3), respectively.
2.3. Yeast two-hybrid screen
The yeast strain used in the two-hybrid screen was HF7C with His,
Trp, and Leu as selection markers and the cDNA library was from a
mouse 7-day embryo as described previously [2]. Yeast cells were trans-
formed with the LiAc-based method. Before the library screen, it was
conﬁrmed that there was no transcriptional activation by the bait pro-
tein (full-length Elmo1). More than 10 million independent colonies
were screened on the selective plate containing 5 mM 3-amino-1,2,4-
triazole (3-AT) without His, Trp and Leu. The yeast clones growing on
the selective plate were restreaked on the selective plate and grown
into single colonies. The plasmid mixtures were then isolated from
each clone after liquid culture of the yeast cells. The prey plasmids
were rescued by transforming each plasmid mixtures into KC8
Escherichia coli and the rescued plasmids were re-transformed into
HF7C yeast cells to conﬁrm the speciﬁc interaction. After conﬁrmation
of the speciﬁc interaction, the prey vectors were sequenced to identify
the inserts. Six ﬁnal candidate genes putatively interacting with Elmo1
in yeast were identiﬁed from this screen.
2.4. Immunoblotting and immunoprecipitation
Primary cells or transfected cells were washed with ice-cold PBS
and then lysed with a lysis buffer containing 50 mM Tris–Cl (pH 7.6),
150 mM NaCl, 10 mM NaPP, 10 mM NaF, 1 mM Na3VO4, 1% Triton
X-100 and protease inhibitor cocktail. Proteins in the lysates were
separated by SDS-PAGE, transferred onto a nitrocellulose membrane,
and detected by appropriate antibodies. For the immunoprecipita-
tion assays, primary cells, cell lines, or transiently transfected cells
were washed with PBS and lysed. Lysates were incubated with
protein-A/G-conjugated agarose beads and appropriate antibodies
for 2 h. Finally, the agarose beads were extensively washed, proteins
bound to agarose beads separated by SDS-PAGE, and transferred
onto a nitrocellulose membrane. Then the immunoprecipitated or
co-immunoprecipitated proteins were detected by immunoblotting.
2.5. Immunostaining
LR73 phagocytes transfected with the indicated plasmids were
cultured on 18 mm Ø glass coverslips in a 12-well non-culture plate
and incubatedwithﬂuorescent apoptotic thymocytes in a CO2 incubator
at 37 °C for 2 h. Afterwards, the cells was washed with ice-cold PBS,
ﬁxedwith 4%paraformaldehyde in PBS for 15min at room temperature,
rinsed with PBS, and incubated with Hoechst 33342 (Invitrogen) in PBS
for 5min at room temperature. Images were acquired on Zeiss Axio Im-
ager A1. NIH3T3 cells cultured on 18 mm Ø coverslips, inside a 12-well
non-tissue-culture plate, were transfected, washed with ice-cold PBS
and ﬁxed with 4% paraformaldehyde in PBS for 15 min at RT. Then the
cells were permeabilized with 0.1% PBST for 5 min and blocked with
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(USB), 0.1% sodium azide (Sigma) and 1% HINGS (Gibco) in PBS for
30min at room temperature. Next, the cellswere incubatedwith prima-
ry antibody (anti-FLAG, Sigma) in 3% BSA in PBS at 4 °C overnight,
washed with PBS and incubated with a secondary antibody (goat anti-
mouse Ig conjugated to Alexa Fluor 555, invitrogen) for 1 h at room
temperature. The cells were washedwith PBS and stainedwith Hoechst
33342 (Invitrogen). Images were acquired using the Zeiss LSM 700
microscope.
2.6. Phagocytosis assay
1 × 105 LR73 cells, L cells, or MEF were transiently transfected with
the indicated plasmids in a 24-well plate with Lipofectamine 2000 or
nucleofection, respectively. One day after transfection, the cells were
incubated with either 1.0 μl of 2 μm carboxylate beads, modiﬁed red
ﬂuorescence beads (Invitrogen), or ﬂuorescent dye-stained apoptotic
thymocytes in a CO2 incubator at 37 °C for 2 h. For the generation of
ﬂuorescent apoptotic thymocytes, the thymi were acquired from
5–6 weeks old C57/Bl6 mice, cell clumps gently dissociated with a
5 ml syringe piston, and sieved to isolate individual thymocytes. Thy-
mocytes were then stained with 25 μM of TAMRA-SE (Invitrogen) or
1 μMCypHer5e (GE Healthcare) in serum-free RPMI in a 5% CO2 incuba-
tor at 37 °C for 20 min. Then the cells were destained in RPMI with 10%
serum for 20 min, washed once and resuspended in RPMI with 10%
serumand 1% penicillin–streptomycin–glutamine. Apoptosis of the thy-
mocytes was induced using 50 μM of dexamethasone (calbiochem) in
an incubator with 5% CO2 at 37 °C for 4 h, and then washed with RPMI
with 10% serum three times. Afterwards, apoptotic thymocyteswere re-
suspended at a concentration of 5 × 105 cells in 300 μl of phagocyte cul-
turemedium and added to phagocytes and incubated in an incubator 5%
CO2 at 37 °C. Phagocyteswere thenwashedwith ice-cold PBSﬁve times,
trypsinized, and analyzed by ﬂow cytometry. Phagocytes were identi-
ﬁed by GFP ﬂuorescence and ingested targets were identiﬁed by red
(from TAMRA) or blue (from CypHer5E) ﬂuorescence. The GFP- and
red- or blue-ﬂuorescent cells were considered to be phagocytes
engulﬁng their targets. Most of the double-positive cells were phago-
cytes engulﬁng their targets or being engulfed themselves, but is not
likely to be phagocytes loosely attached to their targets due to the ex-
tensive number of washes and trypsinization.
2.7. Puriﬁcation of GST, GST-N20, GST-Arhgef16 and Elmo1 from bacteria
BL21 cells were transformedwith pGEX-4T-2-Arhgef16, pGEX-4T-2-
N20, or pGEX-4T-2 and inducedwith 1mM IPTG. 4 h after induction, the
cells were lysed and the lysates were incubated with glutathione-
Sepharose beads for 4 h at 4 °C. The beadswere thenwashed extensive-
ly and resuspended in washing buffer containing 20% glycerol. For puri-
ﬁcation of bacterially produced Elmo1, Elmo1 was puriﬁed using
IMPACT (intein mediated puriﬁcation with an afﬁnity chitin-binding
tag, NEB) system according to the manufacturer's instructions. Brieﬂy,
BL21 cells were transformed with pTYB21-Elmo1 and induced with
1mMIPTG for 4 h and then the cellswere lysed. The lysateswere loaded
onto a chitin column, washed with cleavage buffer containing 50 mM
DTT, and ﬁnally Elmo1 was eluted. GST-tagged proteins and Elmo1
were mixed in 500 μl of a reaction buffer containing 20 mM Tris–Cl
(pH 7.5), 200 mM NaCl and 1 mM EDTA and incubated for 2 h at 4 °C.
After that, bound proteins were separated on SDS-PAGE, transferred
onto nitrocellulose membrane and detected by western blot.
2.8. Quantitative RT-PCR
Total RNA from cell lines, tissues, and primary cells was isolated
using the RNeasy kit (Qiagen) according themanufacturer's instructions
and cDNA was synthesized from total RNA using Superscript III First-
Strand Synthesis System (Invitrogen) based on the manufacturer'sinstructions. The relative levels of the transcripts were evaluated by
the StepOnePlus real-time PCR system (Applied Biosystems) using the
cDNA as the templates.
2.9. CRIB pull-down assay
293 T or LR73 cellswere transfectedwith the indicated plasmids and
then cultured for two or one day, respectively. Cell lysates from the
transfected 293 T or LR73 cells were incubated with bacterially
produced GST-CRIB proteins bound to glutathione-Sepharose beads
for 1 h at 4 °C. Bound proteins on the beads were separated and detect-
ed using the Rac1-speciﬁc antibody.
2.10. Statistical analysis
All data are shown as the mean ± standard deviation. A two-tailed
t-test was used to analyze statistical differences. Statistical signiﬁcance
was calculated using the GraphPad Prism 6 software and signiﬁcance
was assumed when p values were b0.05.
3. Results
3.1. Identiﬁcation of Elmo1 interacting proteins
To identify novel Elmo1-interacting proteins, we performed a yeast
two-hybrid screen using Elmo1 as bait. One candidate clone resulting
from the screen was a fragment of Arhgef16, clone N20, containing
amino acids 234 to 378 of Arhgef16 (Fig. 1A). Only yeast cells expressing
both Elmo1 and the Arhgef16 fragment (N20) grew on the selective
plate unlike yeasts transformed with only Elmo1 or the Arhgef16 frag-
ment (Fig. 1B). To determine whether the interaction between Elmo1
and Arhgef16 could also be found in mammalian cells, FLAG-tagged
Elmo1 and GST-tagged clone N20 were expressed in 293 T cells. GST-
tagged N20 co-immunoprecipitated with FLAG-tagged Elmo1 (Fig. 1C),
providing strong evidence that the fragment of Arhgef16 identiﬁed
from the screen binds to Elmo1 in mammalian cells as well. In order to
narrow the Elmo1 binding region within the N20 fragment, two smaller
fragments, N20F (containing amino acids 234 to 287) and N20R (con-
taining amino acids 288 to 378), were used for additional pull-down as-
says (Fig. 1A). Elmo1 speciﬁcally bound to N20R but not N20F (Fig. 1D);
moreover, although the N20R fragment of Arhgef16 pulled down both
the N-terminal and full-length Elmo1, it failed to pull down C-terminal
Elmo1 (Fig. 1E). These data suggest that the N-terminus of Elmo1 inter-
acts with Arhgef16.
3.2. Arhgef16 interacts directly with Elmo1
To conﬁrm that full-lengthArhgef16 is capable of binding Elmo1, GFP-
tagged Arhgef16 and FLAG-tagged Elmo1 were co-expressed in 293 T
cells. GFP-tagged Arhgef16 was found to co-immunoprecipitate with
Elmo1 when FLAG-tagged Elmo1 was immunoprecipitated (Fig. 2A). Be-
cause over-expression of proteins could result in non-speciﬁc interac-
tions, we also looked at the interactions between endogenous Elmo1
and either overexpressed or endogenous Arhgef16. Endogenous Elmo1
co-immunoprecipitated not only with overexpressed Arhgef16 in 293 T
cells but alsowith endogenousArhgef16 inHeLa cells (Fig. 2B andC), sug-
gesting that Elmo1 binds to Arhgef16 at physiologically relevant protein
levels. However, the weak interaction of Elmo1 with Arhgef16 at physio-
logically relevant levels was observed, which might be caused by the
close proximity of the interaction site in Arhgef16 to the antibody (anti-
Arhgef16) epitope (amino acids 175 to 225 of humanArhgef16). Analysis
of images generated by confocal microscopy also supports our assertion
that Elmo1 and Arhgef16 are interacting proteins. When Elmo1,
Arhgef16, or both Elmo1 and Arhgef16 were expressed in NIH/3T3 cells,
Elmo1 was found to be largely localized in the cytoplasm although it
was sometimes detected faintly in the nucleus while Arhgef16 was
Fig. 1. Identiﬁcation of an Elmo1 interacting protein from a yeast two-hybrid screen. A. Schematic diagram of Arhgef16. The clone identiﬁed in the yeast two-hybrid screen and the cloned
fragments used in this study are indicated. B. Yeast cells transformedwith the indicated plasmidswere plated on a selective plate containing 5mM3-AT and deﬁcient for histidine, leucine
and tryptophan or on the non-selective plate deﬁcient for leucine and tryptophan. E1, Elmo1. C, D, E. 293 T cells were transfected with the indicated plasmids, lysed, and the cell lysates
were immunoprecipitated with the FLAG-speciﬁc antibody (C) or precipitated with glutathione Sepharose beads (D, E). Co-immunoprecipitated proteins (C) or co-precipitated proteins
(D, E) were resolved by SDS-PAGE and detected with the GST-speciﬁc antibody (C) or the FLAG-speciﬁc antibody (D, E). TCL, total cell lysate; and E1, Elmo1.
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were co-expressed, the two proteins co-localized distinctly in the cyto-
plasm (Fig. 2D).
Because these assays could not demonstrate direct interaction of the
proteins, we performed in vitro binding assays to determine whether
the interaction is direct or possibly mediated by a third protein. Recom-
binant GST-N20, GST-Arhgef16 and Elmo1 were expressed and puriﬁed
from bacteria and in vitro pull-down assay was performed using
glutathione-conjugated agarose beads. Both GST-N20 and GST-
Arhgef16 pulled down Elmo1, albeit with different binding strengths,
but GST alone failed to precipitate Elmo1 (Fig. 2E). These binding assays
provide evidence that Elmo1 and Arhgef16 interact directly. Together,
results from these in vitro pull-down assays and the data from yeast,
where neither Elmo nor Arhgef16 homologs exist, suggest that the in-
teraction between Elmo1 and Arhgef16 is a direct protein–protein
interaction.
The functional domains of Arhgef16, especially the DH domain, are
well conserved among members of the Ephexin family. We found that
N20R, containing a part of the DH domain of Arhgef16, binds to Elmo1
and this raised the possibility that Elmo1 interacts with the other
Ephexins. Therefore, we cloned Ephexin-1 and Ephexin-2 to determine
whether Elmo1 could interact with them. Surprisingly, Elmo1 also
interacted with Ephexin-1 and Ephexin-2 although they associated
with Elmo1 relatively weakly compared to Arhgef16 (Fig. 2F). These re-
sults are interesting because other members of the Ephexin family are
known to activate RhoA [20–22,24,25]. In addition,we tested the interac-
tion between Arhgef16 and Elmo homologs. Interestingly, Elmo2
interacted with Arhgef16 much more strongly than Elmo1 but wecould detect no interaction between Elmo3 and Arhgef16 (Fig. 2G).
These data suggest that Elmo may function as a general modulator for
members of the Ephexin family.
3.3. Arhgef16 promotes the engulfment of apoptotic cells
It is known that Elmo functions with Dock1 as a bipartite GEF to ac-
tivate Rac1 and that Elmo is involved in the phagocytosis of apoptotic
cells by Rac1-mediated actin cytoskeleton reorganization. Because
Elmo is important for clearing apoptotic cells, we examined the role of
Arhgef16 during phagocytosis of two types of targets, carboxylate-
modiﬁed beads mimicking apoptotic cells or apoptotic thymocytes.
Arhgef16 over-expression in LR73 phagocytes promoted engulfment
of 2 μm carboxylate-modiﬁed beads compared to the GFP control, and
engulfment of the beads was further increased in cells expressing great-
er amounts of Arhgef16 (Fig. 3A). Analysis by ﬂuorescence microscopy
also conﬁrmed that Arhgef16 promotes engulfment of apoptotic cells.
A higher frequency of LR73 phagocytes expressing Arhgef16 contained
apoptotic bodies compared to a GFP control (Fig. 3B).
To demonstrate that the increase in engulfment of apoptotic cells
mediated by Arhgef16 was caused by increased internalization rather
than increased binding of the targets, two parallel experiments were
performed. First, images generated by confocal microscopy conﬁrmed
apoptotic bodies inside phagocytes in Arhgef16-expressing cells rather
than simply being attached to the phagocytes (Fig. 3C). Second, to focus
on phagocyteswith completely internalized apoptotic cells, the apopto-
tic cells were stainedwith CypHer5E, a pH-sensitive dyewhose ﬂuores-
cence increases when apoptotic cells enter the acidic environment of
Fig. 2.Arhgef16 directly interacts with Elmo1. A, B. 293 T cells were transfectedwith the indicated plasmids, lysed, and the cell lysates were immunoprecipitatedwith anti-FLAG antibody.
Co-immunoprecipitated proteinswere detectedwith the GFP-speciﬁc (A) or Elmo1-speciﬁc antibodies (B). E1, Elmo1; and TCL, total cell lysate. C. HeLa cells were lysed and Arhgef16 was
immunoprecipitatedwith anti-Arhgef16. Co-immunoprecipitated proteinswere detectedwith the Elmo1-speciﬁc antibody. D. NIH/3T3 cells were transfectedwith the indicated plasmids
and stainedwith anti-FLAG antibody. Scale bar, 30 μm. E. GST, GST-N20, GST-Arhgef16 and Elmo1were puriﬁed from bacteria, incubated in a reaction buffer for 2 h, and precipitatedwith
glutathione Sepharose beads. The precipitates were resolved by SDS-PAGE, transferred to a nitrocellulose membrane, and detected by immunoblot analysis. F, G. 293 T cells were
transfected with the indicated plasmids, lysed, and the cell lysates were immunoprecipitated with anti-FLAG antibody. Co-immunoprecipitated proteins were detected by anti-GFP
antibody.
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higher percentage of CypHer5E-positive cells compared to a GFP control
(Fig. 3D). Moreover, analysis by ﬂow cytometry suggests that Arhgef16
facilitates engulfment of apoptotic cells by internalization because un-
bound or loosely bound apoptotic cells are removed during the prepara-
tion of samples due to repeated washes and trypsinization. These data
support the notion that Arhgef16 promotes engulfment of apoptotic
cells through increased internalization of apoptotic bodies.
Clearance of apoptotic cells is an energy-dependent process that re-
quires actin cytoskeleton rearrangement and “dragging” forces inside
the cells, generated by myosin-II, to completely internalize the apopto-
tic bodies. To address whether enhanced removal of apoptotic cells by
Arhgef16 is also governed by the engulfment machinery, LR73 phago-
cytes expressing Arhgef16 with apoptotic cells were incubated with cy-
tochalasin D (an inhibitor of actin polymerization), ML-7 (an inhibitor
of myosin light chain kinase), sodium azide (an inhibitor of ATP synthe-
sis), or by incubating the cells at 4 °C (to inhibit ATP-dependent cellular
processes). Interestingly, Arhgef16-induced engulfment of apoptotic
cells was completely abrogated by these treatments (Fig. 3E), indicating
that the increased uptake of apoptotic cells mediated by Arhgef16 de-
pends on the generally known cytoskeletal engulfment machinery.
The expression of Arhgef16 is not ubiquitous but is conﬁned to
certain tissues and cell types. For example,Arhgef16 transcriptswere de-
tected predominately in thymic epithelial cells and astrocytes (Fig. 3F).
To verify that knockdown of Arhgef16 results in loss of function, prima-
ry astrocytes expressing Arhgef16 endogenously were transfected with
Arhgef16 siRNA or a control siRNA. Expression of Arhgef16 transcripts in
Arhgef16 siRNA-transfected cells was reduced by up to 60% compared to
the control experiment (Fig. 3G) and engulfment of apoptotic cells in
Arhgef16 siRNA-transfected cells was lower than in control siRNA-transfected cells (Fig. 3H). Collectively, these data suggest that en-
hanced engulfment of targets mediated by Arhgef16 results from in-
creased internalization of targets, which is an ATP-dependent process
and requires cytoskeleton rearrangement.
3.4. Elmo is necessary for Arhgef16 function
Next, we determined whether Elmo1 is necessary for Arhgef16-
mediated engulfment of apoptotic targets. To address this possibility,
LR73 phagocytes expressing Arhgef16, Elmo1, or both Arhgef16 and
Elmo1 were incubated with surrogate targets or apoptotic cells. Elmo1
expression in LR73 cells did not promote engulfment of either
carboxylate-modiﬁed beads or apoptotic thymocytes. In contrast, expres-
sion of Arhgef16 in LR73 cells increased the percentage of cells ingesting
surrogate targets or apoptotic cells. Interestingly, when Arhgef16 and
Elmo1 were expressed together in LR73 cells, there was a synergistic in-
crease in engulfment of both types of targets (Fig. 4A and B). In order to
test further the necessity of Elmo1 for Arhgef16 function, a slightly differ-
ent strategy was used. When Elmo1 was depleted and Arhgef16 was
expressed (Fig. 4C), Arhgef16 expressing J774 cells surprisingly failed to
increase uptake of the beads or apoptotic cells. However, J774 cells ex-
pressing both Elmo1 and Arhgef16 showed substantially higher levels
of engulfed carboxylate beads or apoptotic thymocytes (Fig. 4D and E).
These results provide unequivocal evidence that Elmo1 is necessary for
Arhgef16-mediated engulfment of apoptotic cells.
To demonstrate the speciﬁcity and relevance of the interaction be-
tween Arhgef16 and Elmo1 during clearance of apoptotic cells, we
performed additional binding and competition assays. Our yeast two-
hybrid data and immunoprecipitation assays in mammalian cells
showed that Arhgef16 clone N20 binds to Elmo1 more vigorously than
Fig. 3.Arhgef16 promotes engulfment of apoptotic cells. A. LR73 phagocytes transfectedwith GFP or various amounts of Arhgef16were incubatedwith 1 μl of red ﬂuorescent carboxylate-
modiﬁed bead (2 μm in diameter) for 1 h, 1 day after transfection. The cells were extensively washed with ice-cold PBS, trypsinized, and analyzed by ﬂow cytometry. Red ﬂuorescence-
positive cells, in cells expressing equivalent levels of proteins gated on the basis of GFP expression, were considered to be phagocytes engulﬁng the beads. B. LR73 phagocytes transfected
withGFP (left) or Arhgef16 andGFP (right)were incubatedwith TAMRA-labeled apoptotic thymocytes for 2 h, stained, and analyzedbyﬂuorescencemicroscopy. Arrows indicate engulfed
apoptotic cells. Scale bar, 10 μm. C. LR73 phagocytes expressing Arhgef16-GFP were incubated with TAMRA-stained apoptotic thymocytes for 2 h, stained, and analyzed by confocal mi-
croscopy. The numbers indicate the height from bottom set in the microscope. Scale bar, 10 μm. D. CypHer5E-stained apoptotic thymocytes were incubated with LR73 cells transfected
with GFP or Arhgef16-GFP for 2 h. Afterwards, phagocytes were analyzed by ﬂow cytometry. GFP and CypHer5E double-positive phagocytes were considered to be phagocytes internal-
izing apoptotic cells. E. LR73 phagocytes transfected with either GFP alone or GFP and Arhgef16 were incubated with TAMRA-stained apoptotic thymocytes in the presence of NaN3
(1 mM), cytochalasin D (1 μM), ML-7 (30 μM), or at 4 °C. Phagocytes engulﬁng targets were analyzed by ﬂow cytometry. Cont, control; Cyto, cytochalasin D; and NS, not signiﬁcant. F.
cDNAwas synthesized from the indicated cell lines or tissues and then the Arhgef16 transcripts were ampliﬁed by polymerase chain reaction. mDC,mature dendritic cells; iDC, immature
dendritic cells; TEC, thymic epithelial cells; PEC, peritoneal exudate cells; astro, astrocytes; BM, bone marrow; Spln, spleen; and Thy, thymus. G. Total RNA from primary astrocytes
nucleofected with control siRNA or Arhgef16-speciﬁc siRNA was extracted, cDNA was synthesized, and Arhgef16 transcripts were detected by qRT-PCR. Inset, Arhgef16 transcripts from
the nucleofected cells were ampliﬁed using conventional PCR. Cont, control; AG16, Arhgef16. H. Primary astrocytes transfected with control siRNA or Arhgef16-speciﬁc siRNA were incu-
batedwith TAMRA-stained apoptotic thymocytes and the cells engulﬁng apoptotic thymocytes were evaluated by ﬂow cytometry. Data are shown as themean± standard deviation and
are representative of at least three independent experiments. *P b 0.05, **P b 0.01, and ***P b 0.001.
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fragment might block binding of full-length Arhgef16 to Elmo1. Inter-
estingly, the N20 fragment competed with full-length Arhgef16 for
binding to Elmo1, that is, it inhibited the interaction between Elmo1
and full-length Arhgef16 (Fig. 4F). More intriguingly, expression of the
Arhgef16 fragment severely inhibited engulfment of apoptotic cells in
a dose-dependent manner in primary astrocytes expressing Arhgef16
endogenously (Fig. 4G). In addition, expression of the Arhgef16 N20
fragment in LR73 phagocytes overexpressing Elmo1 and Arhgef16
disrupted the synergistic effect of the two proteins and also inhibited
the ability of Arhgef16 to remove apoptotic cells (Fig. 4H). These data
suggest that Elmo1 is necessary and its interaction with Arhgef16 is re-
quired for Arhgef16-mediated uptake of apoptotic cells.
3.5. Arhgef16 promotes engulfment of apoptotic cells in a
Dock1-independent and RhoG-dependent manner
Arhgef16 is a guanine nucleotide exchange factor for the Rho family of
GTPases and it is known to be a RhoG-speciﬁc GEF that can activate Rac1
through the RhoG–Elmo–Dock4 pathway [26]. Because the activation of
Rac1 is a critical step in the removal of apoptotic cells and it is known
that Arhgef16 can activate Rac1 through the activation of RhoG, enhanced
apoptotic cell clearance by Arhgef16may be also mediated by the activa-
tion of Rac1. To test this possibility, we used a CRIB pull-down assay to
measure the levels of activated (or GTP-bound) Rac1 in Arhgef16 overex-
pressing cells. Expression of Arhgef16 in LR73 cells resulted in increased
activation of Rac1 (1.5 fold increase) compared to mock-transfectedcells. More interestingly, and consistent with our previous observations,
the activation of Rac1 in cells overexpressing Arhgef16 was more promi-
nent when Elmo1 was co-expressed (2.4 fold increase) (Fig. 5A). Next,
we used a dominant-negative form of Rac1 (RacN) to further evaluate
the dependency of Arhgef16-mediated engulfment on Rac1. Co-
expression of RacN and Arhgef16 effectively negated any increases in up-
take of apoptotic cells mediated by Arhgef16 (Fig. 5B). These results
strongly suggest that Rac1 is activated in phagocytes overexpressing
Arhgef16, which results in increased uptake of apoptotic cells. Also, the
synergy between Elmo1 and Arhgef16 that allows increased clearance
of apoptotic cells results from an incremental increase in Rac1 activation.
Dock1 is a well-known Elmo binding protein and activates Rac1 dur-
ing the engulfment of apoptotic cells. Thus, we examinedwhether Dock1
is necessary for Arhgef16-induced engulfment of apoptotic cells. First, ex-
pression of Dock1-ISP, a dominant-negative formof Dock1 unable to bind
to Rac1, strongly inhibited a basal level of engulfment of apoptotic cells.
Surprisingly, co-expression of Dock1-ISP and Arhgef16 in LR73 phago-
cytes showedminimally impaired engulfment compared to cells express-
ing only Dock1-ISP (Fig. 5C). Second, to test the effect of Dock1 depletion
on Arhgef16-mediated engulfment, Dock1 expression was reduced by
Dock1-speciﬁc siRNA in MEF and L cells. Decreasing Dock1 transcript
levels had no effect on Arhgef16-mediated engulfment of apoptotic
cells in MEF (Fig. 5D and E) and L cells (Fig. 5F and G) although approxi-
mately 80% of the Dock1 transcripts were depleted by the siRNA
treatment.
It has beenproposed that Arhgef16 is a RhoG-speciﬁc GEF that trans-
duces signals to downstreammolecules through Elmo and Dock4. Thus,
Fig. 4. Elmo is required for Arhgef16-mediated engulfment of apoptotic cells. A, B. LR73 phagocytes were transfected with the indicated plasmids and then incubatedwith red ﬂuorescent
carboxylate-modiﬁed beads (A) or TAMRA-stained apoptotic thymocytes (B) for 2 h and then subjected to ﬂow cytometry. Cells positive for GFP and red ﬂuorescence were considered to
be phagocytes engulﬁng their targets. E1, Elmo1; AG16, Arhgef16. C. J774 cells stably expressing control or Elmo1 siRNAwere transfectedwith Arhgef16, lysed, and immunoblotted. Cont,
control; E1, Elmo1; and AG16, Arhgef16. D, E. J774 cells stably expressing control or Elmo1 siRNA were transfected with GFP or Arhgef16 and GFP, and incubated with red ﬂuorescent
carboxylate-modiﬁed beads (D) or TAMRA-stained apoptotic thymocytes (E). Flow cytometry was used to gate GFP and red ﬂuorescent double-positive cells which were phagocytes
ingesting targets. NS, not signiﬁcant. F. 293 T cells were transfected with the indicated plasmids and immunoprecipitation assay was performed with anti-FLAG antibody. Co-
immunoprecipitated proteins were detected with anti-GFP antibody. G. Primary astrocytes expressing different amounts of the Arhgef16 fragment (N20) interacting with Elmo1 were
incubated with TAMRA-stained apoptotic thymocytes and analyzed by ﬂow cytometry. Expression levels of the Arhgef16 fragment were detected by immunoblot analysis and shown
at the bottom. H. The indicated plasmids were introduced into LR73 cells, and then the cells were incubated with TAMRA-stained apoptotic thymocytes. Flow cytometry analysis was
used to evaluate phagocytes ingesting apoptotic cells. E1, Elmo1; AG16, Arhgef16; and NS, not signiﬁcant. Data are shown as the mean ± standard deviation and are representative of
at least three independent experiments. *P b 0.05, and **P b 0.01.
2444 J. Lee et al. / Biochimica et Biophysica Acta 1843 (2014) 2438–2447we also investigated the possibility that RhoG relays signals generated
by Arhgef16 to downstream molecules during clearance of apoptotic
cells. RhoGN, a dominant-negative form of RhoG, lowered basal uptake
levels of apoptotic cells in LR73 cells.More interestingly, the presence of
RhoGN in Arhgef16-expressing cells completely blocked Arhgef16-
mediated engulfment of apoptotic cells (Fig. 6A). To further evaluate
the role of RhoG during apoptotic cell clearance mediated by Arhgef16,
expression of RhoGwas knocked-downusingRhoG-speciﬁc siRNA. RhoG
transcript levels in these siRNA transfected MEFs were about 70% less
than control siRNA transfected MEFs (Fig. 6B). Intriguingly, Arhgef16
could not facilitate engulfment of surrogate targets or apoptotic cells
when RhoGwas depleted (Fig. 6C andD). This same experimentwas re-
peated with L cells and RhoG transcript levels were also effectively re-
duced by the siRNA treatment (Fig. 6E), which suppressed Arhgef16-
induced engulfment of surrogate targets (Fig. 6F). Taken together,
these results suggest that Arhgef16 mediates engulfment of apoptotic
cells in a Dock1-independent and RhoG-dependent manner and it con-
sists of a parallel pathway from Dock1 for the activation of Rac1 during
engulfment of apoptotic cells.
4. Discussion
Removal of apoptotic cell is an essential biological process inmulticel-
lular organisms during development, formaintaining tissue homeostasis,
and for immune system regulation. Genetic studies using C. elegans as amodel organism have helped to identify several genes involved in the
clearance of cell corpses. CED-12 was originally identiﬁed from these
studies and it functions together with CED-5 to activate CED-10 [11,28,
29]. Mammalian homologs of CED-12, CED-5, and CED-10 are Elmo,
Dock1, and Rac1, respectively, and it is known that Elmo is the regulatory
component of the Elmo-Dock1 bipartite GEF complex responsible for ac-
tivating Rac1 [3,11,30].
Elmo is an intriguing protein that modulates the activities of other
proteins although it does not have intrinsic catalytic activity. Thus far,
various proteins including a plasma membrane protein and a nuclear
protein have been identiﬁed as Elmo-interacting proteins [1,2,7,31].
However, there might be other unidentiﬁed proteins whose activities
are regulated directly by Elmo1. Therefore, we performed a yeast two-
hybrid screen to search for Elmo1-binding proteins and to determine
whether their activities are modulated by Elmo1. We have identiﬁed
six new candidate proteins that interact with Elmo1, apart from previ-
ously identiﬁed and characterized Elmo1 binding partners including
RhoG and Dock1. One candidate from our screen was Arhgef16 and
we veriﬁed the interaction between Elmo1 and Arhgef16 inmammalian
cells; furthermore, this interaction was direct (protein-to-protein) as
determined by in vitro binding assays.
Over-expression of Arhgef16 in phagocytes promoted engulfment of
apoptotic cells and co-expression of Elmo1 and Arhgef16 synergistically
increased engulfment of targets such as surrogate beads and apoptotic
cells. In contrast, depletion of Elmo1 abrogated the enhanced uptake
Fig. 5. Arhgef16 promotes engulfment of apoptotic cells in a Rac1-dependent manner. A. LR73 cells were transiently transfected with the indicated plasmids. 1 day after transfection, the
cells were lysed. GTP-Rac1 was precipitated with GST-CRIB and detected by immunoblot analysis. A representative experiment is shown (left). Active Rac1 levels in the transfected cells
were quantiﬁed using the ImageJ program (right). TCL, total cell lysate. AG16, Arhgef16, E1, Elmo1. B, C. LR73 cells expressing indicated proteinswere incubatedwith TAMRA-stained ap-
optotic thymocytes and analyzed by ﬂow cytometry. AG16, Arhgef16; D-ISP, Dock1-ISP. D, MEF cells were nucleofected with control siRNA or Dock1-speciﬁc siRNA. One day after
nucleofection, total RNA from the nucleofected cells was extracted, cDNA was synthesized, and Dock1 transcripts were detected using qRT-PCR. Inset, Dock1 transcripts from siRNA
nucleofected cells were ampliﬁed by conventional PCR. E,MEF cells nucleofectedwith the indicated siRNA and plasmids were incubatedwith TAMRA-stained apoptotic cells and analyzed
by ﬂow cytometry. F, L cells were transfected with the indicated siRNA, and Dock1 transcript levels were detected by qRT-PCR or conventional PCR (inset). G. L cells transfected with the
indicated siRNA and plasmidswere subjected to an engulfment assay. Data are shown as themean± standard deviation and are representative of at least three independent experiments.
*P b 0.05, **P b 0.01, and ***P b 0.001.
Fig. 6. RhoG mediates Arhgef16-promoted engulfment of apoptotic cells. A. LR73 cells were transfected with the indicated plasmids, incubated with TAMRA-stained apoptotic cells, and
analyzed by ﬂowcytometry. GFP and TAMRAdouble-positive phagocyteswere considered to be phagocytes ingesting targets. B.MEF cells were nucleofectedwith control or RhoG-speciﬁc
siRNA, and cDNA was synthesized from total RNA extracted from the nucleofected cells. RhoG transcript levels were detected by qRT-PCR or conventional PCR (inset). C, D. MEF cells
nucleofected with the indicated siRNA or plasmids were incubated with carboxylate beads (C) or TAMRA-stained apoptotic cells (D). After incubation, phagocytosis of targets was eval-
uated using ﬂow cytometry. E. L cells were transfected with control or RhoG-speciﬁc siRNA. RhoG messages were detected by qRT-PCR or conventional PCR (inset). F. L cells were
transfected with the indicated plasmids and siRNA and then incubated with carboxylate beads. Engulfment of surrogate targets by phagocytes was measured by ﬂow cytometry. Data
are shown as the mean ± standard deviation and are representative of at least three independent experiments. *P b 0.05, and ***P b 0.001.
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Arhgef16 was linked to the activation of Rac1, and Rac1 activation was
signiﬁcantly greater when Elmo1 was co-expressed with Arhgef16.
These observations bear a striking resemblance to the mechanism
used by Dock1 to activate Rac1, with a key difference being that
Dock1 itself has intrinsic GEF activity for Rac1. Here, Elmo helps to
relieve of the self-inhibitory state of Dock1, thereby stabilizing
nucleotide-free Rac, and allowing Dock1 to access Rac1 [12,14,15,32].
In contrast, Arhgef16 is a RhoG-speciﬁc GEF and it is thought that
Arhgef16 activates Rac1 by utilizing the RhoG–Elmo–Dock4 pathway
[26]. Our preliminary observations suggest that the SH3 domain of
Arhgef16 binds to Elmo as well as to itself, as does the amino-terminal
SH3 domain of Dock1 (unpublished data). Thus, Elmo may regulate
the GEF activity of Arhgef16 by relieving the self-inhibitory state of
Arhgef16, as it does for Dock1. This would allow RhoG to become acti-
vated by Arhgef16, followed by Rac1 activation. This might be a general
mechanism whereby Elmo alleviates inhibitory intramolecular interac-
tions, thereby helping to regulate the activities of Elmo-interacting
GEFs. This will be an interesting subject for future study.
Also, we found that Arhgef16 transcripts were restricted to certain
cell lines or tissues, especially the brain or cell lines derived from the
brain. However, Dock1 is ubiquitously expressed. The different expres-
sion patterns of Dock1 and Arhgef16might explain why Rac1 is activat-
ed directly or indirectly by two different GEFs during engulfment of
apoptotic cells. It is plausible that Dock1 is the major GEF for Rac1 in
most phagocytes including professional phagocytes such as macro-
phage and dendritic cells whereas Arhgef16 is specialized to function
mainly in non-professional phagocytes such as astrocytes where
Arhgef16 transcripts are plentiful. In support of this view, it has been re-
ported that astrocytes are highly phagocytic cells capable of clearing ap-
optotic cells, and that Elmo and Arhgef16 are highly expressed in
astrocytes [2,33,34]. Additionally, one interesting ﬁnding of our study
is that Arhgef16-induced engulfment of apoptotic cells is Dock1-
independent although Rac1 becomes activated. Thus, it is interesting
to learn of how Rac1 becomes activated. Previously, it was reported
that Arhgef16 might activate Rac1 through Dock4 [26]. However, we
found that Dock4 is not expressed inMEF or L cells used in the study. In-
stead, Dock3 andDock5 are expressed (data not shown). Thus, it is plau-
sible that the activation of Arhgef16 is channeled into Dock3 or Dock5 to
activate Rac1 at least in these phagocytes, MEF or L cells.
The protein just upstreamof Arhgef16 and presumably necessary for
regulating engulfment of apoptotic cells is unknown. Previously, it was
shown that Arhgef16 binds to the ephrin receptor A2 (EphA2). Howev-
er, it is not knownwhether EphA2 or another unidentiﬁed protein func-
tions as the receptor upstream of Arhgef16 for apoptotic cells. BAI1, an
apoptotic cell receptor, is expressed highly in the brain and astrocytes
and also interacts with Elmo. Thus, BAI1 is also a candidate receptor
that could function just upstream of Arhgef16. It will be interesting to
determine what proteins are upstream of Arhgef16 and involved in
the removal of apoptotic cells.
The evidence presented here suggests that Arhgef16 is an Elmo1-
binding protein. Moreover, Arhgef16 activates Rac1 in a RhoG-
dependent and Dock1-independent manner and there is greater Rac1
activation in the presence of both Arhgef16 and Elmo1. Cooperation be-
tween Arhgef16 and Elmo1 may help to activate RhoG resulting in the
activation of Rac1, which results in a synergistic increase in engulfment
of apoptotic cells. However, the mechanism by which Elmo helps
Arhgef16 activate RhoG needs to be clariﬁed in future studies. Ultimate-
ly, the knowledge gained from these studiesmay be harnessed to devel-
op cures for diseases resulting fromdefects of removal of apoptotic cells.
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